发明授权
US06326401B1 Formulation for the oromucosal, in particular pernasal, route 失效
组织粘膜,特别是鼻窦,路线

Formulation for the oromucosal, in particular pernasal, route
摘要:
A liquid pharmaceutical formulation for administration by the oro-mucosal route, comprising at least one non-polypeptidic active substance and less than 5% W/W of capryl caproyl macrogol glycerides, process for its preparation and it uses.
信息查询
0/0